DNAprint Genomics (DNAG)

[chiggah]

"In my opinion it explains why big pharma decided not to pursue the 'old' technology drug possibilities such as PT-401, as they could do a much better job of discovering the underlying genetic variances that led to the symptoms addressed by such drugs, and tailor therapies to directly address those variances."

Oh, and meanwhile, 160,000 people a year are dying from "old drug" reactions.

There is NO consensus on "these boards" that personalized medicine means choosing between existing drugs to match a person's genetic makeup. That is something YOU made up. We all know, and above all else, Frudakis knows that personalized medicine will address variances in an individual's symptoms demonstrated by a particular sickness and tendencies thereof, and customizing a drug and therapy for that person. We have all known that for years.
To try and and insinuate that DNAPrint just wants to take old drugs and enhance them is shortsighted and deceptive.

PT-401 and other compounds that are enhanced will keep some companies (such as DNAPrint) in business while they become leaders in personalized medicine in the long run.
Your denial of such realities won't spread here. Give a little more credit where credit is due.